Skip to main content
Skip to main content
AMHC logo

Amplitude Healthcare Acquisition Corporation (AMHC)

$10.23 $-0.42 (-3.94%) |CouncilHOLD · 45 · C
Bottom line: HOLD — our Council read (45/100) and AI Score (45/100) broadly agree.
MCap: $1.12B| Vol: 245.4K| 52-wk range: $10.00 – $11.44
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Amplitude Healthcare Acquisition Corporation (AMHC) trades at $10.23 with AI Score 45/100 (Grade C). Amplitude Healthcare Acquisition Corporation (AMHC) is a special purpose acquisition company (SPAC) founded in 2019. Market cap: $1.12B, Sector: Financial services.

Price live · AI analysis from Jun 15, 2026
Amplitude Healthcare Acquisition Corporation (AMHC) is a special purpose acquisition company (SPAC) founded in 2019. It aims to acquire assets and businesses through a merger or similar combination with one or more companies in the healthcare or healthcare-related industries.

Analyst Coverage for AMHC: AMHC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AMHC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 45/100 · C

AMHC: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Amplitude Healthcare Acquisition Corporation (AMHC) Financial Services Profile

CEOBalaji Venkataraman
Employees1
HeadquartersNew York City, US
IPO Year2019

Amplitude Healthcare Acquisition Corporation (AMHC) operates as a special purpose acquisition company, established in 2019, with the strategic intent to identify and merge with one or more businesses within the healthcare or healthcare-related industries. Lacking significant operations itself, AMHC's market position is defined by its pursuit of a transformative business combination.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for AMHC?

Amplitude Healthcare Acquisition Corporation (AMHC) presents an investment thesis centered on its potential to successfully execute a transformative business combination within the healthcare sector. The primary value driver is the prospective merger with a high-growth, innovative private healthcare company, which would transition AMHC from a shell entity into an operating business with intrinsic value. A key growth catalyst would be the announcement and successful completion of a definitive agreement for such an acquisition, followed by shareholder approval and the subsequent de-SPAC transaction. This event would unlock the potential for the combined entity to capitalize on market opportunities within the healthcare industry. The company's $1.12B market capitalization reflects investor anticipation of such a future event. However, a significant risk factor is the inherent uncertainty of identifying and successfully merging with a suitable target within the SPAC's defined operational timeframe. The experienced management team, as highlighted, is a potential strength in navigating the complex acquisition landscape, yet the absence of a current operating business means the investment is speculative, contingent entirely on future M&A success.

Based on FMP financials and quantitative analysis

AMHC Key Highlights

  • Market capitalization stands at $1.12 billion, reflecting investor anticipation of a future business combination.
  • Operates as a special purpose acquisition company (SPAC) with no significant ongoing business operations.
  • Strategically focused on identifying and acquiring a target company within the healthcare or healthcare-related industries.
  • Founded in 2019, signifying its relatively recent establishment in the SPAC market.
  • Maintains a lean operational structure with one employee, consistent with its shell company status.

Who Are AMHC's Competitors?

AMHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NSH NavSight Holdings, Inc. $9.93 +3.01% 69
LRGR Luminar Media Group, Inc. $0.50 +47.06% $22.39M 68
LMAOU LMF Acquisition Opportunities, Inc. $12.46 +41.59% 68
APXTW Apex Treasury Corporation $0.37 +5.11% $1.96B 66
DGNR Dragoneer Growth Opportunities Corp. $9.26 +0.00% $5.79B 57
KWM K Wave Media Ltd. $0.15 -2.40% $10.04M 57
IOAC Innovative International Acquisition Corp. $9.60 -14.44% $100.74M 57
ROCGU Roth CH Acquisition IV Co. $10.29 +2.90% $57.15M 57

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AMHC's Key Strengths?

  • Experienced management team guiding the acquisition strategy.
  • Dedicated focus on the healthcare and healthcare-related industries, a sector known for innovation and growth.
  • Access to public market capital for a potential transformative acquisition.

What Are AMHC's Weaknesses?

  • No significant operations or revenue-generating assets of its own.
  • Reliance on identifying and successfully merging with a suitable target company.
  • Limited operational timeframe to complete a business combination.

What Could Drive AMHC Stock Higher?

  • Announcement of a definitive agreement for a business combination with a target company in the healthcare sector. This event would signal the successful identification of a merger candidate and outline the proposed terms of the transaction.
  • Shareholder vote and subsequent approval of a proposed business combination. This critical milestone is required to finalize the de-SPAC transaction and transition AMHC into an operating entity.
  • Completion of the de-SPAC transaction, resulting in the acquired healthcare company becoming publicly traded through AMHC. This marks the culmination of the SPAC's initial purpose and the beginning of the combined entity's operational phase.

What Are the Key Risks for AMHC?

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Insider selling — insiders were net sellers of roughly $1.9M recently.
  • Uncertainty of identifying and successfully merging with a suitable target company within the defined timeframe, which could lead to liquidation if no deal is completed.
  • Failure to secure the necessary shareholder approval for a proposed business combination, which could derail a potential merger and force the company to seek new targets or liquidate.
  • Dilution of existing shareholder value if a business combination requires significant additional capital raises or if the terms of the merger are unfavorable.
  • Intense competition from other Special Purpose Acquisition Companies (SPACs), private equity firms, and strategic buyers for attractive acquisition targets in the healthcare sector.

What Are the Growth Opportunities for AMHC?

  • Successful De-SPAC Transaction: The most significant growth opportunity for Amplitude Healthcare Acquisition Corporation lies in the successful identification, negotiation, and completion of a business combination with a high-potential private company in the healthcare sector. This event would transform AMHC from a non-operating shell company into a revenue-generating, publicly traded entity. The market size for healthcare M&A remains robust, with significant capital available for innovative companies. A well-executed de-SPAC transaction, potentially within the next 12-24 months, could unlock substantial value by providing the acquired company with public market access and growth capital, thereby creating a new, dynamic operating business for AMHC shareholders.
  • Accessing High-Growth Healthcare Sub-sectors: By focusing on the healthcare or healthcare-related industries, AMHC has the opportunity to merge with a company operating in a rapidly expanding sub-sector, such as biotechnology, digital health, medical devices, or specialized pharmaceuticals. These areas often exhibit significant innovation, strong market demand, and substantial growth potential. For instance, the global digital health market is projected to reach hundreds of billions of dollars by the end of the decade. A strategic acquisition in such a segment could position the combined entity for accelerated revenue growth and market penetration, leveraging emerging trends and technological advancements over a multi-year horizon.
  • Leveraging Management Expertise for Value Creation: The experienced management team guiding Amplitude Healthcare Acquisition Corporation's acquisition strategy represents a crucial growth driver. Their expertise in deal sourcing, due diligence, and transaction execution within the healthcare industry can be instrumental in identifying an undervalued or high-potential target. This specialized knowledge and network can lead to a more favorable acquisition, potentially securing a company with strong intellectual property, established market position, or disruptive technology. The ability of the management to effectively integrate the acquired business and provide strategic guidance post-merger could drive long-term value creation for shareholders.
  • Capitalizing on Public Market Access for Target Companies: AMHC offers a compelling alternative for private healthcare companies seeking public market access. This pathway can be faster and potentially less dilutive than a traditional IPO, allowing the target company to raise significant capital for expansion, research and development, or strategic acquisitions. For a private company, gaining public market visibility can enhance its brand, attract talent, and provide liquidity for existing shareholders. By facilitating this transition, AMHC creates value for both the target company and its own shareholders, positioning the combined entity for accelerated growth and market recognition over the medium term.
  • Strategic Synergies and Post-Merger Expansion: A successful business combination could unlock significant strategic synergies between AMHC's capital and the acquired healthcare company's operations. These synergies might include enhanced access to funding for R&D, expanded market reach through new distribution channels, or operational efficiencies from shared resources. Post-merger, the combined entity could pursue further organic growth initiatives, strategic partnerships, or bolt-on acquisitions to consolidate its market position and diversify its product or service offerings. This strategic expansion, driven by the initial de-SPAC transaction, could lead to sustained revenue growth and increased profitability over the long term.

What Opportunities Does AMHC Have?

  • Successful merger with a high-growth, innovative private healthcare company.
  • Capitalizing on the dynamic trends and significant investment in the healthcare sector.
  • Providing a unique pathway for private companies to access public markets and growth capital.

What Threats Does AMHC Face?

  • Inability to identify or agree on terms with a suitable acquisition target within the specified timeframe.
  • Intense competition from other SPACs, private equity firms, and strategic buyers for attractive healthcare assets.
  • Risk of liquidation if no business combination is completed, leading to redemption of shares.
  • Potential for shareholder dissent or failure to approve a proposed merger.

What Are AMHC's Competitive Advantages?

  • As a non-operating Special Purpose Acquisition Company (SPAC), it does not possess a traditional competitive moat based on products, services, or market share.
  • Its competitive advantage primarily stems from the expertise, industry network, and deal-sourcing capabilities of its management team.
  • Access to the capital raised through its initial public offering provides a significant financial resource for pursuing acquisitions.

What Does AMHC Do?

Amplitude Healthcare Acquisition Corporation (AMHC), founded in 2019 and headquartered in New York, New York, operates as a special purpose acquisition company (SPAC). Distinct from traditional operating companies, AMHC does not possess significant business operations or revenue-generating activities of its own. Its singular corporate mandate is to effectuate a business combination with one or more target entities. This objective is to be achieved through various transactional structures, including a merger, share exchange, share purchase, reorganization, or any similar business combination. The company has specifically delineated its focus on the expansive healthcare or healthcare-related industries, aiming to identify a suitable private enterprise within this sector to bring to the public market. As a shell company, AMHC's operational footprint is minimal, reflected by its lean structure with a single employee. Its existence is predicated on the successful identification, negotiation, and completion of an acquisition. The formation of AMHC represents a strategic vehicle designed to provide private companies within the healthcare ecosystem with an alternative pathway to public listing, bypassing the traditional initial public offering (IPO) process. This model allows the target company to access public capital markets and potentially accelerate its growth trajectory, while offering AMHC's shareholders the opportunity to participate in the future success of a combined, operating entity. The company's current market position is that of a pre-acquisition entity, with its value proposition intrinsically linked to the expertise of its management team in sourcing and executing a high-quality de-SPAC transaction within its specified timeframe. Its strategic focus on healthcare positions it to potentially capitalize on innovation and growth trends prevalent across pharmaceuticals, biotechnology, medical devices, and digital health.

What Products and Services Does AMHC Offer?

  • Operates as a Special Purpose Acquisition Company (SPAC) with no significant ongoing business operations.
  • Formed with the explicit purpose of raising capital to acquire an existing private company.
  • Seeks to identify and execute a business combination with one or more target businesses.
  • Focuses its acquisition strategy exclusively on companies within the healthcare or healthcare-related industries.
  • Aims to complete transactions through various structures, including mergers, share exchanges, or share purchases.
  • Provides an alternative pathway for private healthcare companies to become publicly traded entities.
  • Founded in 2019 and is headquartered in New York, New York.

How Does AMHC Make Money?

  • Does not generate revenue from traditional business operations; its "business" is the acquisition process itself.
  • Raises capital through an initial public offering (IPO) to fund a future business combination.
  • The value proposition for investors is tied to the successful identification and acquisition of a high-growth private company.
  • Upon successful completion of a de-SPAC transaction, the combined entity would adopt the business model of the acquired operating company.

What Industry Does AMHC Operate In?

Amplitude Healthcare Acquisition Corporation operates within the "Shell Companies" industry, a segment of the broader "Financial Services" sector. This industry primarily comprises entities like SPACs, which are formed with the sole purpose of raising capital through an initial public offering to acquire an existing private company. These companies do not possess ongoing business operations, revenue streams, or products, distinguishing them from traditional operating businesses. Within the financial services landscape, SPACs serve as alternative investment vehicles and a non-traditional route for private companies to access public markets. The competitive landscape for AMHC includes other SPACs actively seeking acquisition targets, as well as traditional private equity firms and venture capital funds that also invest in and facilitate growth for private enterprises. AMHC's specific focus on the healthcare or healthcare-related industries positions it to potentially capitalize on the dynamic trends and significant capital flows within that sector, competing for attractive targets against a broad array of financial sponsors.

Who Are AMHC's Key Customers?

  • As a Special Purpose Acquisition Company (SPAC), Amplitude Healthcare Acquisition Corporation does not have traditional customers.
  • Its primary stakeholders are its public shareholders who invest in the SPAC's units or shares.
  • Potential target companies in the healthcare sector are the entities it seeks to acquire, rather than customers.
AI Confidence: 66% Updated: Jun 15, 2026

Net sellingInsider Activity

The most recent 12 insider filings for Amplitude Healthcare Acquisition Corporation break down as 12 sales and 0 purchases. On net that is roughly 188K shares disposed (about $1.9M), a signal worth weighing alongside the fundamentals.

AMHC Valuation & Market Position

With a $1.12B market cap, Amplitude Healthcare Acquisition Corporation sits in the small-cap segment of the market. Relative to its peer group, AMHC's quantitative score of 45/100 is below the peer average of 65/100.

ROE 0%Key Financial Metrics

Return on equity for Amplitude Healthcare Acquisition Corporation stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -6.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.26 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9Financial Health

Amplitude Healthcare Acquisition Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 17.37 places it in the safe zone, indicating low near-term bankruptcy risk.

Company Profile

Amplitude Healthcare Acquisition Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Balaji Venkataraman. AMHC has traded publicly since 2019.

AMHC Financials

Fundamental Snapshot

EPS Growth (FY)
+19.2%
Free Cash Flow Growth (FY)
-22.2%
Current Ratio
2.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence from leadership, indicating a positive outlook for the company.
  • Social sentiment has shifted positively, with discussions around strategic partnerships gaining traction among investors.
  • The healthcare sector's resilience has bolstered interest in healthcare SPACs, making AMHC more appealing to investors.
  • Community discussions highlight potential growth in telehealth and digital health solutions, areas where AMHC is focusing its efforts.

Bear Case

  • Concerns about the overall SPAC market have resurfaced, leading to skepticism about AMHC's long-term viability.
  • Recent social sentiment shows mixed feelings, with some community members expressing doubts about the company's execution on its business plan.
  • Increased regulatory scrutiny on SPACs may create additional hurdles for AMHC, causing apprehension among investors.
  • Market perception remains cautious, with some analysts questioning the sustainability of recent bullish trends in healthcare acquisitions.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

AMHC Latest News

No recent news available for AMHC.

AMHC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMHC.

Price Targets

Wall Street price target analysis for AMHC.

AMHC MoonshotScore

45/100

What does this score mean?

The MoonshotScore rates AMHC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Balaji Venkataraman

Chief Executive Officer

The detailed professional background and educational history of Balaji Venkataraman are not provided in the available source data. As the Chief Executive Officer, he is responsible for managing Amplitude Healthcare Acquisition Corporation's operations, which primarily involve overseeing the strategic direction and execution of the company's mandate to identify and complete a business combination. His role is critical in leading the search for a suitable target company within the healthcare or healthcare-related industries.

Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Balaji Venkataraman's leadership at Amplitude Healthcare Acquisition Corporation are not detailed in the provided information. His track record is understood to be focused on guiding the special purpose acquisition company through its pre-combination phase, including the critical process of target identification and due diligence. The success of AMHC's core objective, a transformative merger, would be a key indicator of his leadership.

Amplitude Healthcare Acquisition Corporation Financial Services Stock: Key Questions Answered

What is Amplitude Healthcare Acquisition Corporation's primary business objective?

Amplitude Healthcare Acquisition Corporation (AMHC) operates as a Special Purpose Acquisition Company (SPAC), meaning its core business objective is not to conduct ongoing commercial operations but rather to identify and acquire an existing private company. Specifically, AMHC was formed in 2019 with the intent to achieve a business combination—such as a merger, share exchange, or share purchase—with one or more businesses operating within the healthcare or healthcare-related industries. Its purpose is to provide an alternative pathway for a private company to become publicly traded, leveraging the capital raised by AMHC to fuel the acquired entity's growth and market expansion.

What are the key risks associated with investing in a Special Purpose Acquisition Company (SPAC) like AMHC?

Investing in a SPAC like Amplitude Healthcare Acquisition Corporation carries several distinct risks due to its unique business model. A primary risk is the uncertainty of identifying and successfully completing a business combination with a suitable target company within the stipulated timeframe. If AMHC fails to do so, it typically liquidates, returning capital to shareholders, potentially at or near the initial trust value but without any upside. Other risks include potential dilution from warrants or future capital raises, the valuation of the target company, and the possibility of shareholder disapproval for a proposed merger. The success of the investment is entirely contingent on the quality of the eventual acquisition.

How does Amplitude Healthcare Acquisition Corporation identify and evaluate potential acquisition targets in the healthcare sector?

While specific details on Amplitude Healthcare Acquisition Corporation's proprietary target identification and evaluation process are not explicitly provided, its stated intent is to acquire businesses in the healthcare or healthcare-related industries. Typically, SPACs like AMHC leverage the extensive industry network and expertise of their management team, which, in AMHC's case, is led by Balaji Venkataraman. This team is responsible for sourcing, conducting due diligence on, and negotiating with potential target companies. The evaluation process would likely involve assessing a target's market position, growth potential, financial health, management quality, and strategic fit within the broader healthcare landscape, aiming for a transformative combination.

What are the key factors to evaluate for AMHC?

Amplitude Healthcare Acquisition Corporation (AMHC) holds an AI score of 45/100 (low). Not financial advice.

How frequently does AMHC data refresh on this page?

AMHC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven AMHC's recent stock price performance?

Amplitude Healthcare Acquisition Corporation (AMHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team guiding the acquisition strategy. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AMHC overvalued or undervalued right now?

Valuing Amplitude Healthcare Acquisition Corporation (AMHC) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying AMHC?

Before investing in Amplitude Healthcare Acquisition Corporation (AMHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is limited by the nature of a Special Purpose Acquisition Company (SPAC) which has no significant operations prior to a business combination.
  • Specific details on management's prior track record and target identification criteria are not provided in the source data.
Data Sources

Popular Stocks